Vanda Pharmaceuticals Inc. (VNDA)
NGM · Common · CUSIP 921659108
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for VNDA and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
921659108
Market Cap
Small Cap
Business: Vanda Pharmaceuticals Inc. is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. The Company uses new technologies, including genetics and genomics, to inform its drug discovery, clinical trials, and its commercial positioning of its compounds.

Company Contact

CEO
Mihael H. Polymeropoulos
CFO
Kevin Moran
Headquarters
2200 Pennsylvania Avenue NW, Suite 300E, Washington, DC 20037
Phone
202-734-3400
Investor Relations
Kevin Moran · 202-734-3400 · pr@vandapharma.com
Email Form
Request Form »
SEC EDGAR Filings
View filings »